Proscia Inc., of Philadelphia, reported that Unity Biotechnology Inc., of South San Francisco, has deployed its Concentriq digital pathology platform to advance its research and development pipeline, which is focused on developing therapeutics to slow, halt or reversing diseases of aging.
Featured Story:
Latest Articles
December 19, 2024
December 3, 2024